C
Carmen Spaccarotella
Researcher at Magna Græcia University
Publications - 118
Citations - 1851
Carmen Spaccarotella is an academic researcher from Magna Græcia University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 77 publications receiving 1131 citations.
Papers
More filters
Journal ArticleDOI
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
Salvatore De Rosa,Carmen Spaccarotella,Cristina Basso,Maria Pia Calabrò,Antonio Curcio,Pasquale Perrone Filardi,Massimo Mancone,Giuseppe Mercuro,Saverio Muscoli,Savina Nodari,Roberto Pedrinelli,Gianfranco Sinagra,Ciro Indolfi +12 more
TL;DR: Admissions for AMI were significantly reduced during the COVID-19 pandemic across Italy, with a parallel increase in fatality and complication rates.
Journal ArticleDOI
The Outbreak of COVID-19 in Italy: Fighting the Pandemic
TL;DR: In Italy, the unexpected pandemic of COVID-19 has caused a never-seen-before disaster in terms of hospitalizations and deaths as discussed by the authors, which caused a new coronavirus, SARS-Cov-2.
Journal ArticleDOI
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes
Carmen Spaccarotella,Alberto Polimeni,Serena Migliarino,Elisa Principe,Antonio Curcio,Annalisa Mongiardo,Sabato Sorrentino,Salvatore De Rosa,Ciro Indolfi +8 more
TL;DR: Use of ECGs recorded on smartwatches might be useful to obtain an earlier diagnosis of acute coronary syndromes; these data need to be further examined in patients with suspected myocardial infarction in whom false-positive and false-negative findings could be better characterized.
Journal ArticleDOI
Pathophysiology of aortic stenosis and approach to treatment with percutaneous valve implantation.
TL;DR: Aortic stenosis is the most commonly acquired valvular heart disease in the Western world and the mortality for untreated symptomatic severe AS is up to 50-60% at 2 years in high-risk patients.
Journal ArticleDOI
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor.
Annarita Carino,Salvatore De Rosa,Sabato Sorrentino,Alberto Polimeni,Jolanda Sabatino,Gianluca Caiazzo,Daniele Torella,Carmen Spaccarotella,Annalisa Mongiardo,Antonio Strangio,Carol Filippis,Ciro Indolfi +11 more
TL;DR: Switching from a dual antiplatelet treatment with clopidogrel to ticagrelor is associated with significant modulation in the circulating levels of specific microRNAs, paving the way for the use of circulating microRN as biomarkers of platelets activity in response to specific pharmacological treatments.